Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
暂无分享,去创建一个
M. Manns | F. Lehner | T. Greten | H. Wedemeyer | F. Korangy | Jaba Gamrekelashvili | F. Zhao | Lars A. Ormandy | Bastian Hoechst | T. Voigtlaender
[1] Xuetao Cao,et al. Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11 , 2009, The Journal of Immunology.
[2] P. Tien,et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.
[3] A. Cerwenka,et al. Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells. , 2008, Blood.
[4] M. Manns,et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. , 2008, Gastroenterology.
[5] V. Bronte,et al. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.
[6] G. Altavilla,et al. Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells , 2008, Cancer.
[7] H. Ljunggren,et al. Prospects for the use of NK cells in immunotherapy of human cancer , 2007, Nature Reviews Immunology.
[8] J. Kappes,et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.
[9] Ingo Fricke,et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. , 2006, Cancer research.
[10] M. Manns,et al. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. , 2006, World journal of gastroenterology.
[11] Paolo Serafini,et al. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.
[12] N. Hayashi,et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. , 2005, Journal of hepatology.
[13] J. Blay,et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner , 2005, The Journal of experimental medicine.
[14] D. Olive,et al. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. , 2005, Blood.
[15] S. Signoretti,et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. , 2005, Cancer research.
[16] M. Manns,et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. , 2005, Cancer research.
[17] W. Chang,et al. Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage , 1991, Digestive Diseases and Sciences.
[18] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[19] M. Manns,et al. Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[20] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[21] Diego Piccioli,et al. Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.
[22] Giovanni Melioli,et al. Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.
[23] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[24] J. Ritz,et al. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling , 1999, Nature Medicine.
[25] A. S. Pak,et al. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] G. Trinchieri,et al. Human natural killer cells. , 1979, Transplantation proceedings.